ENvue Medical (FEED) Net Shares Issued and Repurchased (2017 - 2025)
ENvue Medical's (FEED) quarterly Net Shares Issued and Repurchased came in at $95.0 in Q4 2025, down 99.73% year-over-year from $34818.0 in Q4 2024, and little changed quarter-over-quarter from $95.0 in Q3 2025.
Powered by 
Analysis
ENvue Medical (FEED) Net Shares Issued and Repurchased (2017 - 2025) Analysis & Trends
ENvue Medical (FEED) has reported Net Shares Issued and Repurchased for 9 consecutive years, with $95.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased fell 99.73% year-over-year to $95.0 in Q4 2025; TTM through Dec 2025 was $95.0, a 99.73% decrease from a year earlier, with the FY2025 full-year figure at $95.0, down 99.73% from the prior year.
- Net Shares Issued and Repurchased was $95.0 for Q4 2025 at ENvue Medical, roughly flat from $95.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $180000.0 in Q1 2021 and troughed at $95.0 in Q2 2025.
- A 5-year average of $24286.2 and a median of $8883.0 in 2023 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased surged 263.29% in 2024 and slumped 99.73% in 2025, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $13845.0 in 2021, then jumped by 58.0% to $21875.0 in 2022, then tumbled by 56.19% to $9584.0 in 2023, then surged by 263.29% to $34818.0 in 2024, then tumbled by 99.73% to $95.0 in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $95.0 (Q4 2025), $95.0 (Q3 2025), and $95.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 95.00 |
| Sep 30, 2025 | 95.00 |
| Jun 30, 2025 | 95.00 |
| Dec 31, 2024 | 34,818.00 |
| Mar 31, 2024 | 8,182.00 |
| Dec 31, 2023 | 9,584.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 21,875.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 13,845.00 |
| Jun 30, 2021 | 13,845.00 |
| Mar 31, 2021 | 180,000.00 |
| Dec 31, 2020 | 997,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Mar 31, 2019 | 120,000.00 |
| Dec 31, 2018 | 338,750.00 |
| Dec 31, 2017 | 7,160.00 |